David Windley

Jefferies Turns Bullish On Molina, Sees Potential For Upside To Estimates

Humana, Anthem Benefit From 'Attractive' Managed Care Sector, Jefferies Says

The INC Research Pullback Creates A Compelling Entry Point

Humana, Anthem Benefit From 'Attractive' Managed Care Sector, Jefferies Says

The INC Research Pullback Creates A Compelling Entry Point

Jefferies Highlights A Pair Trade In Pharma: Buy ICON, Hold Tight On INC Research

Winners And Losers Amid Affordable Care Act Uncertainty

Jefferies Highlights A Pair Trade In Pharma: Buy ICON, Hold Tight On INC Research

Winners And Losers Amid Affordable Care Act Uncertainty

'Full Potential' For UnitedHealth

A Look At 4 Scenarios For Humana In The Wake Of Trump's Election Win

David Windley Recent News

Jefferies Downgrades ICON To Hold, Cites Lower Bookings, Sales

Looking Past M&A: The Best Managed Care Stock Plays For The Long Haul

How The Street Is Reacting To The Aetna-Humana Deal

Jefferies Boosts Targets Across Pharmaceutical Service Stocks

UPDATE: Jefferies Reiterates On Humana Inc As Management Displays Confidence

Jefferies Analyst Names Favorites In Managed Healthcare Sector

UPDATE: Jefferies Raises PT on WuXi PharmaTech Following Raised 2013 EPS Guidance

UPDATE: Jefferies Raises PT on PAREXEL Following Solid 2Q Results

UPDATE: Jefferies Raises PT on WellCare Health Plans Following Stock Surge

UPDATE: Jefferies Raises PT on UnitedHealth Group Ahead of 2Q Earnings Report

UPDATE: Jefferies Raises PT on Humana Ahead of 2Q Earnings Report

UPDATE: Jefferies Raises PT on Cigna Ahead of 2Q Earnings Report

UPDATE: Jefferies Raises PT on Aetna Ahead of 2Q Earnings Report

UPDATE: Jefferies Raises PT on WellPoint Ahead of 2Q Earnings Report

UPDATE: Jefferies Raises PT on PAREXEL on Tough Margin Outlook, Premium Valuation

UPDATE: Jefferies Raises PT on Centene Following Exit Delay Announcement

UPDATE: Jefferies Initiates Quintiles Transnational at Hold on Valuation

UPDATE: Jefferies Raises PT on Aetna Following Coventry Acquisition

Jefferies Rates Pharmaceutical Product Development ( PPDI) A Buy

Jefferies & Company, Inc. Upgrades Warner Chilcott Ltd. (WCRX) To Buy Rating

ICON (ICLR) Maintains A Buy Rating